• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童病态窦房结综合征的起搏器治疗

Pacemaker treatment of sick sinus syndrome in children.

作者信息

Gillette P C, Shannon C, Garson A, Porter C J, Ott D, Cooley D A, McNamara D G

出版信息

J Am Coll Cardiol. 1983 May;1(5):1325-9. doi: 10.1016/s0735-1097(83)80147-8.

DOI:10.1016/s0735-1097(83)80147-8
PMID:6833672
Abstract

The sick sinus syndrome is being recognized with increasing frequency in children. Although it is sometimes benign, it can be serious or have fatal consequences. Fifty-one patients (mean age 10.5 years) underwent permanent cardiac pacing for sick sinus syndrome. Twenty patients had epicardial ventricular pacing and 12 had an epicardial atrial implant. Seven had endocardial atrial pacing, six epicardial atrioventricular (AV) sequential pacing, four epicardial universal pacing and two endocardial universal pacing. Of the 49 symptomatic patients, 45 had relief of symptoms. Eleven of 18 patients with associated tachyarrhythmias had amelioration of their tachycardia. There were no early but two late deaths unrelated to the pacemakers. Seven patients during a mean follow-up period of 26 months required reoperation for pacing lead or sensing problems. Permanent pacing for sick sinus syndrome in children is a safe and symptomatically effective procedure.

摘要

儿童病窦综合征的确诊率日益增高。尽管该病有时呈良性,但也可能很严重甚至导致致命后果。51例(平均年龄10.5岁)病窦综合征患儿接受了永久性心脏起搏治疗。20例行心外膜心室起搏,12例行心外膜心房植入。7例行心内膜心房起搏,6例行心外膜房室顺序起搏,4例行心外膜通用起搏,2例行心内膜通用起搏。49例有症状的患者中,45例症状缓解。18例合并快速性心律失常的患者中有11例心动过速得到改善。与起搏器无关的早期死亡病例为0,但有2例晚期死亡。平均随访26个月期间,7例患者因起搏导线或感知问题需要再次手术。儿童病窦综合征的永久性起搏是一种安全且症状改善有效的治疗方法。

相似文献

1
Pacemaker treatment of sick sinus syndrome in children.儿童病态窦房结综合征的起搏器治疗
J Am Coll Cardiol. 1983 May;1(5):1325-9. doi: 10.1016/s0735-1097(83)80147-8.
2
Safety and efficacy of AAIR pacing in selected patients with sick sinus syndrome.AAIR起搏在特定病态窦房结综合征患者中的安全性和有效性。
Medicine (Baltimore). 2018 Oct;97(42):e12833. doi: 10.1097/MD.0000000000012833.
3
Use of atrial pacing in a young population.年轻人群中心房起搏的应用。
Pacing Clin Electrophysiol. 1985 Jan;8(1):94-100. doi: 10.1111/j.1540-8159.1985.tb05728.x.
4
Atrial pacing: who do we pace and what do we expect? Experiences with 100 atrial pacemakers.心房起搏:我们对谁进行起搏以及期望达到什么效果?100例心房起搏器植入经验
Pacing Clin Electrophysiol. 1990 May;13(5):625-30. doi: 10.1111/j.1540-8159.1990.tb02079.x.
5
Transvenous permanent pacemaker implantation in children and adolescent.儿童及青少年经静脉永久性起搏器植入术
Acta Paediatr Taiwan. 2001 Nov-Dec;42(6):350-4.
6
Sinus node dysfunction in children and adolescents: treatment by implantation of a permanent pacemaker in 26 patients.
Turk J Pediatr. 2002 Oct-Dec;44(4):312-6.
7
[Left atrial and ventricular epicardial dual chamber pacing through a left lateral thoracotomy to treat pediatric complete atrioventricular block].[经左外侧开胸行左心房与心室心外膜双腔起搏治疗小儿完全性房室传导阻滞]
Zhonghua Er Ke Za Zhi. 2013 Aug;51(8):578-83.
8
Long-term endocardial atrial pacing in children with postoperative bradycardia-tachycardia syndrome and limited ventricular access.术后心动过缓-心动过速综合征且心室通路受限的儿童的长期心内膜心房起搏
Am J Cardiol. 1982 May;49(7):1750-7. doi: 10.1016/0002-9149(82)90255-7.
9
Stability of AV conduction in sick sinus node syndrome patients with implanted atrial pacemakers.植入心房起搏器的病态窦房结综合征患者的房室传导稳定性
Am Heart J. 1984 Apr;107(4):644-7. doi: 10.1016/0002-8703(84)90309-0.
10
[Clinical analysis of pacing therapy and treatment of complications during follow-up in children].[儿童起搏治疗及随访期间并发症处理的临床分析]
Zhonghua Er Ke Za Zhi. 2017 Jul 2;55(7):514-518. doi: 10.3760/cma.j.issn.0578-1310.2017.07.009.

引用本文的文献

1
2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Executive Summary.《2021年儿科患者心血管植入式电子设备适应证与管理的PACE专家共识声明:执行摘要》
Ann Pediatr Cardiol. 2022 May-Jun;15(3):323-346. doi: 10.4103/0974-2069.361245. Epub 2022 Nov 16.
2
Sino-Atrial Node Mapping in Children and Adults With Congenital Heart Disease.先天性心脏病儿童和成人的窦房结标测
Front Pediatr. 2022 Jul 1;10:896825. doi: 10.3389/fped.2022.896825. eCollection 2022.
3
Shenfu Injection: A Famous Chinese Prescription That Promotes Activity in Bone Marrow Mesenchymal Stem Cells.
参附注射液:一种促进骨髓间充质干细胞活性的著名中药方剂。
Evid Based Complement Alternat Med. 2021 Aug 17;2021:9912844. doi: 10.1155/2021/9912844. eCollection 2021.
4
2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: Executive summary.《2021年儿科患者心血管植入式电子设备适应证与管理的PACE专家共识声明:执行摘要》
Indian Pacing Electrophysiol J. 2021 Nov-Dec;21(6):349-366. doi: 10.1016/j.ipej.2021.07.006. Epub 2021 Jul 29.
5
2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients.2021年儿科患者心血管植入式电子设备的适应证与管理PACE专家共识声明
Indian Pacing Electrophysiol J. 2021 Nov-Dec;21(6):367-393. doi: 10.1016/j.ipej.2021.07.005. Epub 2021 Jul 29.
6
Cardiac conduction defects and Brugada syndrome: A family with overlap syndrome carrying a nonsense SCN5A mutation.心脏传导缺陷与布加综合征:一个携带SCN5A无义突变的重叠综合征家族。
J Arrhythm. 2017 Feb;33(1):35-39. doi: 10.1016/j.joa.2016.05.007. Epub 2016 Jul 2.
7
Advances in the treatment of cardiac dysrhythmias.
Indian J Pediatr. 1988 Jan-Feb;55(1):118-26. doi: 10.1007/BF02722566.